These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24294450)

  • 1. Pre- and Post-Angioplasty Perfusion CT with Acetazolamide Challenge in Patients with Unilateral Cerebrovascular Stenotic Disease.
    You SH; Jo SM; Kim YJ; Lee JH; Jo KD; Park WS
    J Korean Neurosurg Soc; 2013 Oct; 54(4):280-8. PubMed ID: 24294450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
    Chen A; Shyr MH; Chen TY; Lai HY; Lin CC; Yen PS
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion-CT assessment of the cerebrovascular reserve: a revisit to the acetazolamide challenges.
    Smith LM; Elkins JS; Dillon WP; Schaeffer S; Wintermark M
    J Neuroradiol; 2008 Jul; 35(3):157-64. PubMed ID: 18242708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking.
    Chabriat H; Pappata S; Ostergaard L; Clark CA; Pachot-Clouard M; Vahedi K; Jobert A; Le Bihan D; Bousser MG
    Stroke; 2000 Aug; 31(8):1904-12. PubMed ID: 10926955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between acetazolamide challenge and 10% carbon dioxide challenge perfusion CT in rat C6 glioma.
    Lu N; Di Y; Feng XY; Qiang JW; Zhang JW; Wang YG; Guo QY
    Acad Radiol; 2012 Feb; 19(2):159-65. PubMed ID: 22212420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging.
    Nighoghossian N; Berthezene Y; Meyer R; Cinotti L; Adeleine P; Philippon B; Froment JC; Trouillas P
    J Neurol Sci; 1997 Aug; 149(2):171-6. PubMed ID: 9171326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation.
    Kang KH; Kim HS; Kim SY
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1487-93. PubMed ID: 18499785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal timing for measuring cerebral blood flow after acetazolamide administration to detect preexisting cerebral hemodynamics and metabolism in patients with bilateral major cerebral artery steno-occlusive diseases:
    Kobayashi M; Igarashi S; Takahashi T; Fujiwara S; Chida K; Terasaki K; Kubo Y; Ogasawara K
    Am J Nucl Med Mol Imaging; 2021; 11(6):507-518. PubMed ID: 35003888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable Temporal Cerebral Blood Flow Response to Acetazolamide in Moyamoya Patients Measured Using Arterial Spin Labeling.
    Fahlström M; Wikström J; Borota L; Enblad P; Lewén A
    Front Neurol; 2021; 12():615017. PubMed ID: 34168605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B; Westera G; Treyer V; Burger C; Khan N; Buck A
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cerebrovascular reserve using xenon-enhanced CT scanning in patients with symptomatic middle cerebral artery stenosis.
    Cao W; Cheng X; Li H; Wang L; Zhang X; Dong Q
    J Clin Neurosci; 2014 Feb; 21(2):293-7. PubMed ID: 24238634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Hemodynamic Compromise Using Computed Tomography Perfusion in Combination with
    Hashimoto A; Mikami T; Komatsu K; Noshiro S; Hirano T; Wanibuchi M; Mikuni N
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):627-635. PubMed ID: 27939758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of acetazolamide challenge test in the evaluation of acute stroke.
    Kashiwagi S; Kitahara T; Shirao S; Moroi J; Kato S; Nakayama H; Wakuta Y
    Keio J Med; 2000 Feb; 49 Suppl 1():A120-1. PubMed ID: 10750359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT perfusion with angiography as a substitute for both conventional digital subtraction angiography and acetazolamide-challenged SPECT in the follow-up of postbypass patients.
    Park JC; Kim JE; Kang HS; Sohn CH; Lee DS; Oh CW; Han MH
    Cerebrovasc Dis; 2010; 30(6):547-55. PubMed ID: 20948198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cerebral blood perfusion reserve with acetazolamide using 3D spiral ASL MRI: Preliminary experience in pediatric patients.
    Hu HH; Li Z; Pokorney AL; Chia JM; Stefani N; Pipe JG; Miller JH
    Magn Reson Imaging; 2017 Jan; 35():132-140. PubMed ID: 27580517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.